Gou Qing, Zhou Zejian, Zhao Mingfang, Chen Xiaoming, Zhou Qing
Department of Interventional Oncology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou 510080, China.
The First Hospital of China Medical University, Department of Medical Oncology, Shenyang 110001, China.
Zhongguo Fei Ai Za Zhi. 2020 Feb 20;23(2):111-117. doi: 10.3779/j.issn.1009-3419.2020.02.06.
Non-small cell lung cancer (NSCLC) is the most common pathological type of primary lung cancer. Currently, main treatment approaches for NSCLC patients include surgical resection, radiotherapy, chemotherapy, targeted therapy and so on. In recent years, thermal ablation has received increasing attention in the treatment of various stages of NSCLC. As a safe and efficient local treatment, thermal ablation may bring potential clinical benefits to NSCLC patients. However, many issues remain unsolved and further investigation is needed in the clinical application of thermal ablation in NSCLC. In this review, we aim to summarize the applications of thermal ablation in NSCLC and further discuss the emerging controversies as well as future research directions.
非小细胞肺癌（NSCLC）是原发性肺癌最常见的病理类型。目前，NSCLC患者的主要治疗方法包括手术切除、放疗、化疗、靶向治疗等。近年来，热消融在NSCLC各阶段治疗中受到越来越多的关注。作为一种安全有效的局部治疗方法，热消融可能给NSCLC患者带来潜在的临床益处。然而，许多问题仍未解决，热消融在NSCLC临床应用中仍需进一步研究。在本综述中，我们旨在总结热消融在NSCLC中的应用，并进一步讨论新出现的争议以及未来的研究方向。
